Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2023 Volume 28 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2023 Volume 28 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling

  • Authors:
    • Bitna Kweon
    • Dong-Uk Kim
    • Jin-Young Oh
    • Sung-Joo Park
    • Gi-Sang Bae
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacology, School of Korean Medicine, Wonkwang University, Iksan, Jeollabuk 54538, Republic of Korea, Hanbang Cardio‑Renal Syndrome Research Center, School of Korean Medicine, Wonkwang University, Iksan, Jeollabuk 54538, Republic of Korea
    Copyright: © Kweon et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 208
    |
    Published online on: September 19, 2023
       https://doi.org/10.3892/mmr.2023.13095
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Chronic pancreatitis (CP) is a pancreatic inflammatory disease associated with histological changes, including fibrosis, acinar cell loss and immune cell infiltration, and leads to damage of the pancreas, which results in pain, weight loss and loss of pancreas function. Catechin or catechin hydrate (CH) has antioxidant, anticancer and immune‑regulatory effects. However, unlike other catechins, the antifibrotic effects of (+)‑CH have not been widely studied in many diseases, including CP. Therefore, the anti‑fibrotic effects of (+)‑CH against CP were evaluated in the present study. To assess the prophylactic effects of CH, (+)‑CH (1, 5 or 10 mg/kg) or ethanol was administered 1 h before first cerulein (50 µg/kg) injection. To assess the therapeutic effects, (+)‑CH (5 mg/kg) or ethanol was administered after cerulein injection for one or two weeks. In both methods, cerulein was injected intraperitoneally into mice once every hour, six times a day, four times a week, for a total of three weeks, to induce CP. The data showed that (+)‑CH markedly inhibited glandular destruction and inflammation during CP. Moreover, (+)‑CH prevented pancreatic stellate cell (PSC) activation and the production of extracellular matrix components, such as fibronectin 1 and collagens, which suggested that it may act as a novel therapeutic agent. Furthermore, the mechanism and effectiveness of (+)‑CH on pancreatic fibrosis were investigated in isolated PSCs. (+)‑CH suppressed the activation of Smad2 and fibrosis factors that act through transforming growth factor‑β (TGF‑β) or platelet‑derived growth factor. These findings suggest that (+)‑CH exhibits antifibrotic effects in cerulein‑induced CP by inactivating TGF‑β/Smad2 signaling.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Yang HY, Wang D, Liu Y, Han C, Xin L, Li ZS, Liao Z and Hu LH: Global status in chronic pancreatitis research. Pancreas. 49:1283–1289. 2020. View Article : Google Scholar : PubMed/NCBI

2 

Olesen SS, Mortensen LH, Zinck E, Becker U, Drewes AM, Nøjgaard C, Novovic S, Yadav D and Tolstrup JS: Time trends in incidence and prevalence of chronic pancreatitis: A 25-year population-based nationwide study. United European Gastroenterol J. 9:82–90. 2021. View Article : Google Scholar : PubMed/NCBI

3 

Etemad B and Whitcomb DC: Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology. 120:682–707. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Olesen SS, Frandsen LK, Poulsen JL, Vestergaard P, Rasmussen HH and Drewes AM: The prevalence of underweight is increased in chronic pancreatitis outpatients and associates with reduced life quality. Nutrition. 43–44. 1–7. 2017.

5 

Lin CH, Yeh NC, Wang JJ, Ho CH, Her SH, Tsay WI and Chien CC: Effect of chronic pancreatitis on complications and mortality in DM patients: A 10-year nationwide cohort study. J Clin Endocrinol Metab. 105:e739–e745. 2020. View Article : Google Scholar

6 

Drewes AM, Krarup AL, Detlefsen S, Malmstrøm ML, Dimcevski G and Funch-Jensen P: Pain in chronic pancreatitis: The role of neuropathic pain mechanisms. Gut. 57:1616–1627. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Madro A: Malnutrition in chronic pancreatitis: Causes, assessment methods, and therapeutic management. Can J Gastroenterol Hepatol. 2020:88754872020.PubMed/NCBI

8 

Kirkegård J, Mortensen FV and Cronin-Fenton D: Chronic pancreatitis and pancreatic cancer risk: A systematic review and meta-analysis. Am J Gastroenterol. 112:1366–1372. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P and Lévy P: Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 119:1324–1332. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Han M, Tran TPT and Oh JK: Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea. Sci Rep. 12:55452022. View Article : Google Scholar : PubMed/NCBI

11 

Muniraj T, Aslanian HR, Farrell J and Jamidar PA: Chronic pancreatitis, a comprehensive review and update. Part I: Epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features. Dis Mon. 60:530–550. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Dufour MC and Adamson MD: The epidemiology of alcohol-induced pancreatitis. Pancreas. 27:286–290. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Koehn FE and Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4:206–220. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Chacko SM, Thambi PT, Kuttan R and Nishigaki I: Beneficial effects of green tea: A literature review. Chin Med. 5:132010. View Article : Google Scholar : PubMed/NCBI

15 

Khan N and Mukhtar H: Tea polyphenols for health promotion. Life Sci. 81:519–533. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Kim HK, Yang TH and Cho HY: Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis. World J Gastroenterol. 15:5200–5205. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Higdon JV and Frei B: Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 43:89–143. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Isemura M: Catechin in human health and disease. Molecules. 24:5282019. View Article : Google Scholar : PubMed/NCBI

19 

Asaumi H, Watanabe S, Taguchi M, Tashiro M, Nagashio Y, Nomiyama Y, Nakamura H and Otsuki M: Green tea polyphenol (−)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells. Eur J Clin Invest. 36:113–122. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Cao Y, Bao S, Yang W, Zhang J, Li L, Shan Z and Teng W: Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet. Nutr Res. 34:1066–1074. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Wei R, Cortez Penso NE, Hackman RM, Wang Y and Mackenzie GG: Epigallocatechin-3-gallate (EGCG) suppresses pancreatic cancer cell growth, invasion, and migration partly through the inhibition of Akt pathway and epithelial-mesenchymal transition: Enhanced efficacy when combined with gemcitabine. Nutrients. 11:18562019. View Article : Google Scholar : PubMed/NCBI

22 

Kim JM and Heo HJ: The roles of catechins in regulation of systemic inflammation. Food Sci Biotechnol. 31:957–970. 2022. View Article : Google Scholar : PubMed/NCBI

23 

EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), . Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, Filipič M, Frutos MJ, Galtier P, Gott D, et al: Scientific opinion on the safety of green tea catechins. EFSA J. 16:e052392018.PubMed/NCBI

24 

Alshatwi AA, Hasan TN, Alqahtani AM, Syed NA, Shafi G, Al-Assaf AH and Al-Khalifa AS: Delineating the anti-cytotoxic and anti-genotoxic potentials of catechin hydrate against cadmium toxicity in human peripheral blood lymphocytes. Environ Toxicol Pharmacol. 38:653–662. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Babich H, Krupka M, Nissim HA and Zuckerbraun HL: Differential in vitro cytotoxicity of (−)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity. Toxicol In Vitro. 19:231–242. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Alshatwi AA: Catechin hydrate suppresses MCF-7 proliferation through TP53/Caspase-mediated apoptosis. J Exp Clin Cancer Res. 29:1672010. View Article : Google Scholar : PubMed/NCBI

27 

Kweon B, Kim DU, Oh JY, Oh H, Kim YC, Mun YJ, Bae GS and Park SJ: Arecae pericarpium water extract alleviates chronic pancreatitis by deactivating pancreatic stellate cells. Front Pharmacol. 13:9419552022. View Article : Google Scholar : PubMed/NCBI

28 

Rai A, Das S, Chamallamudi MR, Nandakumar K, Shetty R, Gill M, Sumalatha S, Devkar R, Gourishetti K and Kumar N: Evaluation of the aphrodisiac potential of a chemically characterized aqueous extract of Tamarindus indica pulp. J Ethnopharmacol. 210:118–124. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Shahid A, Ali R, Ali N, Hasan SK, Bernwal P, Afzal SM, Vafa A and Sultana S: Modulatory effects of catechin hydrate against genotoxicity, oxidative stress, inflammation and apoptosis induced by benzo(a)pyrene in mice. Food Chem Toxicol. 92:64–74. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Bragança de Moraes CM, Bitencourt S, de Mesquita FC, Mello D, de Oliveira LP, da Silva GV, Lorini V, Caberlon E, de Souza Basso B, Schmid J, et al: (+)-Catechin attenuates activation of hepatic stellate cells. Cell Biol Int. 38:526–530. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Zang G, Sandberg M, Carlsson PO, Welsh N, Jansson L and Barbu A: Activated pancreatic stellate cells can impair pancreatic islet function in mice. Ups J Med Sci. 120:169–180. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Steer ML, Waxman I and Freedman S: Chronic pancreatitis. N Engl J Med. 332:1482–1490. 1995. View Article : Google Scholar : PubMed/NCBI

34 

Zimmermann A, Gloor B, Kappeler A, Uhl W, Friess H and Büchler MW: Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans. Gut. 51:574–578. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Gress T, Menke A, Bachem M, Müller-Pillasch F, Ellenrieder V, Weidenbach H, Wagner M and Adler G: Role of extracellular matrix in pancreatic diseases. Digestion. 59:625–637. 1998. View Article : Google Scholar : PubMed/NCBI

36 

Kennedy RH, Bockman DE, Uscanga L, Choux R, Grimaud JA and Sarles H: Pancreatic extracellular matrix alterations in chronic pancreatitis. Pancreas. 2:61–72. 1987. View Article : Google Scholar : PubMed/NCBI

37 

Omary MB, Lugea A, Lowe AW and Pandol SJ: The pancreatic stellate cell: A star on the rise in pancreatic diseases. J Clin Invest. 117:50–59. 2007. View Article : Google Scholar : PubMed/NCBI

38 

Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, Pirola RC, McCaughan GW, Ramm GA and Wilson JS: Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol. 155:1087–1095. 1999. View Article : Google Scholar : PubMed/NCBI

39 

Ohnishi H, Miyata T, Yasuda H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, Makita N, Iiri T, et al: Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions. J Biol Chem. 279:8873–8878. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC and Wilson JS: Pancreatic stellate cells are activated by proinflammatory cytokines: Implications for pancreatic fibrogenesis. Gut. 44:534–541. 1999. View Article : Google Scholar : PubMed/NCBI

41 

Schwarzenberg SJ and Whitcomb DC: Causes and contributing risk factors for chronic pancreatitis in children and adolescents. UpToDate in Medicine.

42 

Duggan SN, Ni Chonchubhair HM, Lawal O, O'Connor DB and Conlon KC: Chronic pancreatitis: A diagnostic dilemma. World J Gastroenterol. 22:2304–2313. 2016. View Article : Google Scholar : PubMed/NCBI

43 

Klöppel G and Maillet B: Pathology of acute and chronic pancreatitis. Pancreas. 8:659–670. 1993. View Article : Google Scholar : PubMed/NCBI

44 

Aghdassi AA, Mayerle J, Christochowitz S, Weiss FU, Sendler M and Lerch MM: Animal models for investigating chronic pancreatitis. Fibrogenesis Tissue Repair. 4:262011. View Article : Google Scholar : PubMed/NCBI

45 

Zheng L, Xue J, Jaffee EM and Habtezion A: Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology. 144:1230–1240. 2013. View Article : Google Scholar : PubMed/NCBI

46 

Saotome T, Inoue H, Fujimiya M, Fujiyama Y and Bamba T: Morphological and immunocytochemical identification of periacinar fibroblast-like cells derived from human pancreatic acini. Pancreas. 14:373–382. 1997. View Article : Google Scholar : PubMed/NCBI

47 

Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A and Adler G: Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 115:421–432. 1998. View Article : Google Scholar : PubMed/NCBI

48 

Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC and Wilson JS: Periacinar stellate shaped cells in rat pancreas: Identification, isolation, and culture. Gut. 43:128–133. 1998. View Article : Google Scholar : PubMed/NCBI

49 

To WS and Midwood KS: Plasma and cellular fibronectin: Distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair. 4:212011. View Article : Google Scholar : PubMed/NCBI

50 

Yamaguchi T, Kihara Y, Taguchi M, Nagashio Y, Tashiro M, Nakamura H and Otsuki M: Persistent destruction of the basement membrane of the pancreatic duct contributes to progressive acinar atrophy in rats with experimentally induced pancreatitis. Pancreas. 31:365–372. 2005. View Article : Google Scholar : PubMed/NCBI

51 

Liu B, Ding Y, Li P, Wang T, He S, Jia Z and Yang J: MicroRNA-219c-5p regulates bladder fibrosis by targeting FN1. BMC Urol. 20:1932020. View Article : Google Scholar : PubMed/NCBI

52 

Sand J, Genovese F and Karsdal M: Type IV collagen. Biochemistry of Collagens, Laminins and Elastin. Elsevier; Amsterdam: pp. 31–41. 2016, View Article : Google Scholar

53 

Hu LH, Ji JT and Li ZS: Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis. J Cell Mol Med. 19:2049–2057. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Attisano L and Wrana JL: Signal transduction by the TGF-beta superfamily. Science. 296:1646–1647. 2002. View Article : Google Scholar : PubMed/NCBI

55 

Gurusamy KS, Lusuku C and Davidson BR: Pregabalin for decreasing pancreatic pain in chronic pancreatitis. Cochrane Database Syst Rev. 2:CD0115222016.PubMed/NCBI

56 

Kwon CI, Cho JH, Choi SH, Ko KH, Tirkes T, Gromski MA and Lehman GA: Recent advances in the diagnosis and management of chronic pancreatitis. Korean J Intern Med. 34:242–260. 2019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kweon B, Kim D, Oh J, Park S and Bae G: Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling. Mol Med Rep 28: 208, 2023.
APA
Kweon, B., Kim, D., Oh, J., Park, S., & Bae, G. (2023). Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling. Molecular Medicine Reports, 28, 208. https://doi.org/10.3892/mmr.2023.13095
MLA
Kweon, B., Kim, D., Oh, J., Park, S., Bae, G."Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling". Molecular Medicine Reports 28.5 (2023): 208.
Chicago
Kweon, B., Kim, D., Oh, J., Park, S., Bae, G."Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling". Molecular Medicine Reports 28, no. 5 (2023): 208. https://doi.org/10.3892/mmr.2023.13095
Copy and paste a formatted citation
x
Spandidos Publications style
Kweon B, Kim D, Oh J, Park S and Bae G: Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling. Mol Med Rep 28: 208, 2023.
APA
Kweon, B., Kim, D., Oh, J., Park, S., & Bae, G. (2023). Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling. Molecular Medicine Reports, 28, 208. https://doi.org/10.3892/mmr.2023.13095
MLA
Kweon, B., Kim, D., Oh, J., Park, S., Bae, G."Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling". Molecular Medicine Reports 28.5 (2023): 208.
Chicago
Kweon, B., Kim, D., Oh, J., Park, S., Bae, G."Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling". Molecular Medicine Reports 28, no. 5 (2023): 208. https://doi.org/10.3892/mmr.2023.13095
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team